MIRA
INFORM REPORT
|
Report Date : |
09.03.2007 |
IDENTIFICATION
DETAILS
|
Name : |
CYGNUS HEALTHCARE SPECIALITIES PRIVATE LIMITED |
|
|
|
|
Registered Office : |
C-2/009, Rutu Estate, Patilpada, Ghod Bunder Road, Thane-400601,
Maharashtra |
|
|
|
|
Country : |
India |
|
|
|
|
Date of Incorporation : |
03.06.2005 |
|
|
|
|
Com. Reg. No.: |
11-153761 |
|
|
|
|
CIN No.: [Company
Identification No.] |
U24230MH2005PTC153761 |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business : |
To carry on in India or abroad the business of manufacturer directly
or through contract manufacturer or on loan basis, export, import, refine,
process, buy, sell, produce, compound, mix, pack, repack, formulate,
condense, distill, rectify, sterilize, steam, evaporate, cool, filter,
extract, operate, purify, protect, preserve and to act as stockiest,
distributors, marketers, consultants, vendor, contractors, suppliers or
otherwise deal in all types, descriptions, applications. Strengths and
application of health care products like pharmaceutical medicaments in life
saving in all its branches including allopathic, ayurvedic, homeopathic
and/or unani or combination thereof used for treatment, cure and health care
of human being and animals, including basic patient drugs, bulk drugs, drug
intermediate patent and proprietory medicines, common medical preparations or
all kind of drugs and medicines, vitamin preparations, herbs, herbal
extracts, either mixture, powder, tablets, capsules, syrups, injectables,
vaccines, biological and non biological capsules, injections and compounds,
tonics biotics, liquid drugs, drops, lotions, ornaments, hair drugs, bath
salts, cream skin preparations, lipsticks, rouges, make-ups, deodorants,
ayurvedic products, toilet articles, perfumery, spirits, pharmaceutical
preparations and descriptions and all products or by products thereof,
intermediates, compound sand ll other
articles of personal hygienic, healthcare, beauty and cosmetics,
contraceptives, infants food, specialist preparations and chemical and
medical equipments, medical devices and detection kits, surgical appliances,
anatomical, infusion set, orthopedic scientific apparatus and materials,
contrivances, appliances, instruments and devices and provider of hospital
requisites, surgical and other ligatures syringes, spirits herbal
preparation, formulations and cosmetics, drugs, druggist biological products. |
RATING &
COMMENTS
|
MIRA’s Rating : |
Ca |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
Maximum Credit Limit : |
|
|
|
|
|
Status : |
New Company |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a new company and yet to establish itself. Company’s first
financials are awaited. No further details or payment could be available. The company can be considered for small business dealings with slight
caution initially. |
LOCATIONS
|
Registered Office : |
C-2/009, Rutu Estate, Patilpada, Ghod Bunder Road, Thane-400601,
Maharashtra, India |
|
|
|
|
Factory 1 : |
32/201, Alpana, Vasant Leela G. B. Road, Thane (West)-400607,
Maharashtra, India |
|
Tel. No.: |
91-22-32975174/ 25862026 |
|
Fax No.: |
91-22-25863693 |
|
Mobile No.: |
91-9323565913 |
|
E-Mail : |
DIRECTORS
|
Name : |
Mr. Ganesan Subramanian Iyer |
|
Designation : |
Director |
|
Address : |
32/201, Alpana, Vasant Leela G. B. Road, Thane (West)-400607,
Maharashtra, India |
|
Date of Appointment : |
03.06.2005 |
|
|
|
|
Name : |
Mrs. Indira Suryanarayanan Iyer |
|
Designation : |
Director |
|
Address : |
Mulund Shree Mahalaxmi Co-operative Housing society Limited, 10th
Floor, Flat No.1002, Near Eastern Express Highway, Mhada, Mulund (East), Mumbai-400081,
Maharashtra, India |
|
Date of Appointment : |
03.06.2005 |
MAJOR SHAREHOLDERS
/ SHAREHOLDING PATTERN
|
Names of Shareholders |
No. of Shares |
|
Mr. Ganesan Subramanian Iyer |
500 |
|
Mrs. Indira Suryanarayanan Iyer |
500 |
|
Total |
1000 |
BUSINESS DETAILS
|
Line of Business : |
To carry on in India or abroad the business of manufacturer directly
or through contract manufacturer or on loan basis, export, import, refine, process,
buy, sell, produce, compound, mix, pack, repack, formulate, condense,
distill, rectify, sterilize, steam, evaporate, cool, filter, extract,
operate, purify, protect, preserve and to act as stockiest, distributors,
marketers, consultants, vendor, contractors, suppliers or otherwise deal in
all types, descriptions, applications. Strengths and application of health
care products like pharmaceutical medicaments in life saving in all its
branches including allopathic, ayurvedic, homeopathic and/or unani or
combination thereof used for treatment, cure and health care of human being
and animals, including basic patient drugs, bulk drugs, drug intermediate
patent and proprietory medicines, common medical preparations or all kind of
drugs and medicines, vitamin preparations, herbs, herbal extracts, either
mixture, powder, tablets, capsules, syrups, injectables, vaccines, biological
and non biological capsules, injections and compounds, tonics biotics, liquid
drugs, drops, lotions, ornaments, hair drugs, bath salts, cream skin
preparations, lipsticks, rouges, make-ups, deodorants, ayurvedic products,
toilet articles, perfumery, spirits, pharmaceutical preparations and
descriptions and all products or by products thereof, intermediates, compound
sand ll other articles of personal
hygienic, healthcare, beauty and cosmetics, contraceptives, infants food,
specialist preparations and chemical and medical equipments, medical devices
and detection kits, surgical appliances, anatomical, infusion set, orthopedic
scientific apparatus and materials, contrivances, appliances, instruments and
devices and provider of hospital requisites, surgical and other ligatures
syringes, spirits herbal preparation, formulations and cosmetics, drugs,
druggist biological products. |
CAPITAL STRUCTURE
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
5000 |
Equity Shares |
Rs.100/- each |
Rs.0.500 millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
1000 |
Equity Shares |
Rs.100/-
each |
Rs.0.100
millions |
LOCAL AGENCY
FURTHER INFORMATION
Website Details :
Profile
Since inception, their organization is steadily growing on
the grounds of quality and innovative product range. They export premium quality
Pharmaceutical Drugs.
They have embarked upon with the aim to be one of the fastest growing and
leading company in their domain by providing unmatched products, incomparable
services at the most competitive prices to their valued customers. They are
committed towards, achieving the highest quality standards, understanding the
customer's need, changing market scenario and delivering products accordingly.
Providing generic versions of popular branded pharmaceuticals
that are produced under Internationally Recognized quality standards in world
class manufacturing facilities
|
Generic
Drugs |
Generic Name |
|
Sildenafil Citrate |
Sildenafil
Citrate |
|
Tadalafil |
Tadalafil
|
|
Vardenafil |
Vardenafil |
|
Finasteride |
Finasteride |
|
Fluoxetine |
Fluoxetine
HCl |
|
Paroxetine |
Paroxetine
HCl |
|
Rofecoxib |
Rofecoxib |
|
Celecoxib |
Celecoxib |
|
Orlistat |
Orlistat
|
|
Sertraline |
Sertraline |
|
Generic
Harmone Drugs |
|
|
Anti
Retrovirals / Anti HIV Drugs |
|
|
Anti
Cancer Drugs |
|
|
Anti
Diabetic Drugs |
|
|
Angina
/ Blood Pressure Drugs |
|
Their
Management Team
Their management team is dedicated to offer R&D based formulations that combines
consumer research and preparation expertise to deliver very specific
experiences into formulations.
Quality Assurance
They follow stringent measures to control the quality of their products. They
have become a reliable name in their chosen field of business. The formulations
are produced at WHO GMP approved facilities.
Customer Satisfaction
By maintaining high level of consistency in terms of products and service
quality, they have established a strong market goodwill and wide client base
that extends globally.
|
Generic
Drugs |
|||
|
Sildenafil Citrate |
Tadalafil |
Vardenafil |
Finasteride |
|
Fluoxetine |
Paraxetine |
Rofecoxib |
Celecoxib |
|
Orlistat |
Sertraline |
Hormone Drugs |
Anti HIV Drugs |
|
Anti Retroviral Drugs |
Anti Cancer Drugs |
Anti Diabetics |
Angine/ Blood Pressure Drugs |
|
Anti Allergy Drugs |
Anti Convulsants |
Anti Fungal |
Asthma |
|
Blood Pressure |
Cholesterol |
Gasto intestinal/ Acidity |
Stop-Smoking |
|
Migraine |
|
|
|
CMT REPORT
(Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts, India Prisons Service,
Interpol, etc.
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE
GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE
RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.22 |
|
UK Pound |
1 |
Rs.85.51 |
|
Euro |
1 |
Rs.58.03 |
SCORE & RATING
EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
2 |
|
PAID-UP CAPITAL |
1~10 |
2 |
|
OPERATING SCALE |
1~10 |
2 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILIRY |
1~10 |
1 |
|
--LIQUIDITY |
1~10 |
2 |
|
--LEVERAGE |
1~10 |
2 |
|
--RESERVES |
1~10 |
2 |
|
--CREDIT LINES |
1~10 |
2 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
NO |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
18 |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING
EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit consideration.
Capability to overcome financial difficulties seems comparatively below
average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|